Top 50 Medical Device VC Funds & Investors (November 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
SOSV
VC Fund
|
201 | United States, China, Canada | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | $25k–$5M |
|
Innova Memphis
VC Fund
|
78 | United States, Germany, Argentina | Seed, Pre-Seed, Convertible Note | Health Care, Medical, Medical Device | $25k–$1.5M |
|
SOSV HAX
VC Fund
|
62 | United States, Canada, China | Seed, Convertible Note, Pre-Seed | Robotics, Software, Manufacturing | $25k–$4.5M |
|
Enterprise Ireland
VC Fund
|
54 | Ireland, United States, United Kingdom | Seed, Venture - Series Unknown, Grant | Software, Health Care, Information Technology | $26k–$8.2M |
|
Bpifrance
VC Fund
|
42 | France, United States, Switzerland | Seed, Venture - Series Unknown, Series A | Software, Health Care, Biotechnology | $752k–$34M |
|
Alumni Ventures
VC Fund
|
41 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Health Care | $850k–$75M |
|
Par Equity
VC Fund
|
38 | United Kingdom, United States, Brazil | Venture - Series Unknown, Seed | Software, Manufacturing, Information Technology | $82k–$4.3M |
|
SFC Capital
VC Fund
|
37 | United Kingdom, United States, Ireland | Seed, Pre-Seed, Venture - Series Unknown | Software, Artificial Intelligence, Information Technology | $125k–$2.5M |
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
36 | Germany, Switzerland, United States | Seed, Series A, Venture - Series Unknown | Software, Biotechnology, Health Care | $680k–$31M |
|
Qiming Venture Partners
VC Fund
|
36 | China, United States, Hong Kong | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $4M–$120M |
|
Keiretsu Forum
VC Fund
|
33 | United States, India, Turkey | Venture - Series Unknown, Seed, Series A | Health Care, Software, Biotechnology | $65k–$8.1M |
|
Artesian VC
VC Fund
|
32 | Australia, United States, China | Seed, Pre-Seed, Venture - Series Unknown | Software, Health Care, Artificial Intelligence | $29k–$17M |
|
Portfolia
VC Fund
|
31 | United States, Canada, Germany | Seed, Series A, Series B | Health Care, Biotechnology, Software | $347k–$51M |
|
Gaingels
VC Fund
|
30 | United States, Canada, United Kingdom | Seed, Series A, Venture - Series Unknown | Software, Artificial Intelligence, Health Care | $72k–$35M |
|
Khosla Ventures
VC Fund
|
30 | United States, United Kingdom, India | Series A, Seed, Series B | Artificial Intelligence, Software, Health Care | $1.6M–$100M |
|
Right Side Capital Management
VC Fund
|
29 | United States, Canada, United Kingdom | Pre-Seed, Convertible Note, Seed | Software, Artificial Intelligence, SaaS | $50k–$1.5M |
|
Zürcher Kantonal Bank
VC Fund
|
29 | Switzerland, Germany, Japan | Seed, Series A, Series B | Health Care, Biotechnology, Medical Device | $1M–$20M |
|
New Enterprise Associates
VC Fund
|
29 | United States, China, India | Series A, Series B, Series C | Software, Health Care, Biotechnology | $5.7M–$100M |
|
Connecticut Innovations
VC Fund
|
29 | United States, Israel, Canada | Seed, Series A, Venture - Series Unknown | Health Care, Biotechnology, Software | $100k–$23M |
|
TEDCO
VC Fund
|
28 | United States, Canada, Colombia | Seed, Grant, Pre-Seed | Health Care, Software, Biotechnology | $25k–$2.5M |
|
Foundation for Innovation and Technology (FIT)
VC Fund
|
28 | Switzerland, France, United States | Debt Financing, Grant, Seed | Health Care, Information Technology, Artificial Intelligence | $20k–$2.5M |
|
Portugal Ventures
VC Fund
|
28 | Portugal, United States, United Kingdom | Seed, Venture - Series Unknown, Pre-Seed | Software, Information Technology, Health Care | $107k–$3.6M |
|
Parkwalk Advisors
VC Fund
|
27 | United Kingdom, United States, Philippines | Seed, Series A, Series B | Biotechnology, Health Care, Software | $991k–$44M |
|
SOSV SF & NY (Fka IndieBio)
VC Fund
|
27 | United States, United Kingdom, Canada | Seed, Pre-Seed, Convertible Note | Biotechnology, Health Care, Medical | $50k–$5M |
|
Keiretsu Capital
VC Fund
|
27 | United States, Canada, India | Series A, Convertible Note, Seed | Health Care, Biotechnology, Software | $50k–$12M |
|
Almi Invest
VC Fund
|
26 | Sweden, Norway, United States | Venture - Series Unknown, Seed | Software, Health Care, Manufacturing | $226k–$3.5M |
|
Broadview Ventures
VC Fund
|
25 | United States, Switzerland, Canada | Series A, Seed, Series B | Health Care, Biotechnology, Medical Device | $1M–$45M |
|
New York Angels
VC Fund
|
25 | United States, Israel, Canada | Seed, Pre-Seed, Series A | Software, Health Care, Artificial Intelligence | $40k–$10M |
|
StartUp Health
VC Fund
|
25 | United States, Canada, United Kingdom | Seed, Venture - Series Unknown, Pre-Seed | Health Care, Medical, Wellness | $20k–$15M |
|
Sofinnova Partners
VC Fund
|
24 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $7M–$105M |
|
First Citizens Innovation Banking
VC Fund
|
24 | United States, Canada, United Kingdom | Debt Financing, Series B, Series A | Software, Health Care, Biotechnology | $2M–$100M |
|
CincyTech
VC Fund
|
23 | United States | Seed, Series A, Series B | Software, Health Care, Biotechnology | $250k–$20M |
|
Launch NY
VC Fund
|
23 | United States, Canada, Denmark | Convertible Note, Seed, Pre-Seed | Software, Health Care, SaaS | $18k–$2.2M |
|
Sand Hill Angels
VC Fund
|
23 | United States, Canada, India | Seed, Convertible Note, Series A | Software, Health Care, Biotechnology | $300k–$25M |
|
TCA Venture Group
VC Fund
|
22 | United States, Canada, South Africa | Seed, Venture - Series Unknown, Convertible Note | Health Care, Software, Biotechnology | $100k–$6.2M |
|
U.S. Venture Partners
VC Fund
|
20 | United States, Israel, Canada | Series B, Series C, Series A | Software, Health Care, Information Technology | $4.7M–$68M |
|
Northstar Ventures
VC Fund
|
20 | United Kingdom, United States, Indonesia | Seed, Venture - Series Unknown, Series A | Software, Information Technology, Health Care | $45k–$10M |
|
HealthTech Capital
VC Fund
|
20 | United States, Canada | Seed, Series A, Convertible Note | Health Care, Medical Device, Medical | $1M–$16M |
|
Oxford Finance LLC
VC Fund
|
19 | United States, United Kingdom, Canada | Debt Financing, Post-IPO Debt, Venture - Series Unknown | Biotechnology, Health Care, Medical | $5M–$150M |
|
Western Development Commission
VC Fund
|
19 | Ireland, United States | Seed, Venture - Series Unknown, Series A | Health Care, Medical Device, Biotechnology | $702k–$17M |
|
Good Growth Capital
VC Fund
|
19 | United States, France, Israel | Seed, Series A, Convertible Note | Health Care, Biotechnology, Software | $25k–$24M |
|
Eniac Ventures
VC Fund
|
19 | United States, Canada, Spain | Seed, Series A, Series B | Software, Artificial Intelligence, Mobile | $1.1M–$40M |
|
Social Starts
VC Fund
|
18 | United States, Canada, Germany | Seed, Series A, Venture - Series Unknown | Software, Health Care, Artificial Intelligence | $50k–$14M |
|
Verve Ventures
VC Fund
|
18 | Switzerland, Germany, France | Series A, Seed, Series B | Software, Health Care, Biotechnology | $1.3M–$45M |
|
MB Venture Partners
VC Fund
|
18 | United States, Israel | Seed, Series B, Series C | Health Care, Medical, Medical Device | $50k–$28M |
|
Texas HALO Fund
VC Fund
|
18 | United States, Canada, Hungary | Seed, Convertible Note, Series A | Health Care, Medical Device, Software | $105k–$10M |
|
Boston Harbor Angels
VC Fund
|
18 | United States, Canada, India | Angel, Seed, Series A | Health Care, Biotechnology, Medical Device | $100k–$6M |
|
Everywhere Ventures
VC Fund
|
18 | United States, United Kingdom, Australia | Seed, Pre-Seed, Series A | Software, Health Care, Artificial Intelligence | $250k–$20M |
|
Versant Ventures
VC Fund
|
18 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $4.7M–$107M |
|
EIT Health
VC Fund
|
17 | United Kingdom, Spain, Ireland | Grant, Pre-Seed, Seed | Health Care, Medical Device, Medical | $27k–$1.7M |
| Access all 11260 VC funds in Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
SOSV offers pre-seed capital and follow-on financial support to startups focusing on deep technology and scientific innovation. Founders utilize purpose-built laboratory facilities and engineering spaces to accelerate product development and testing. The firm facilitates connections between entrepreneurs and a network of investors through structured matchmaking events and technology summits.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, China, Canada
Investor stats
- Total investments: 3821
- Round size: Seed $125k–$5M; Pre-Seed $25k–$1.5M; Convertible Note $50k–$3.6M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $306M in 2023
Portfolio highlights
- Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
- Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.
- Samphire Neuroscience — Samphire Neuroscience builds clinically validated neurotechnology to support women across their lives. Our wearable devices, Nettle™ and Lutea™, are built on the same underlying brain-stimulation technology, targeting neural pathways involved in pain, mood, stress, and sleep regulation. - Lutea™ is available globally as a wellness device. Itstimulates the same regions of the brain to support stress regulation, sleep, and recovery - key drivers of readiness and long-term performance - allowing athletes and teams to move beyond wellbeing education alone to practical, evidence-based intervention. - Nettle™ is a CE-marked (EU and UK regulated), drug- and hormone-free device that has been clinically shown to improve pain, mood, functionality, and the ability to train during the menstrual cycle, with measurable benefits after one month of use - supporting athletes to maintain training intensity and movement quality during their period. - The Samphire App is the platform controlling all Samphire hardware products with the use of CycleSync™ AI technology: the only one of its kind to support personalized neurotechnology use for women.
Innova operates an early-stage venture capital fund specifically targeting the agricultural technology and farm management sectors. The firm provides pre-seed, seed, and series-A financial deployments alongside strategic scaling guidance to startups addressing agricultural biological inputs, automated labor robotics, on-farm data capture systems, and decision-support analytics. Its value proposition centers on supplying crucial initial institutional check liquidity to founders to build economically transformative tools that optimize farmer profitability and backend operation workflows. At Innova we invest in start-up companies, help them grow, and then assist them in linking with established corporations for licensing, buy-outs or further investments. We provide the synergy of experienced management, market expertise and venture capital to accelerate the development of new products and services into viable business units that can stand on their own and then take their place with a mature market leader, if desired. Whether an innovation is still on the drawing board or stalled in the market place the Innova staff has the expertise, skills, and experience to envision and create a functioning business unit that is prepared to thrive in the market place. Technical know-how, market-proven staffing, and "just-right" funding assure the greatest chance possible for success.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United States, Germany, Argentina
Investor stats
- Total investments: 301
- Round size: Seed $25k–$1.5M; Pre-Seed $25k–$1.3M; Convertible Note $48k–$1.4M
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely still investing — raised $40M in 2023
Portfolio highlights
- HerdDogg — HerdDogg is a global herd health and data science platform. It is a two-part system that helps ranchers track health and proximity data from their herd. The company's device gathers the data captured by the ear tags and reports it directly to the rancher via an app or web database.
- Insignum AgTech — Insignum AgTech develops biotech plants that communicate with producers, alerting them to an illness in its early stages.
- Soiltech Wireless — Soiltech Wireless is a developer of ag-tech solutions to design electronic devices for agricultural professionals. Its product provides real-time data to drive efficiency and optimize quality. It also provides actionable data without installation hassles and creates scalable monitoring solutions for farmers.The company was founded in 2019 and isheadquartered in Rupert, Idaho.
HAX is a program for Hard Tech startups taking their first steps towards commercialization. We provide hands-on support and investment as part of SOSV, a $1B AUM multi-stage venture firm.
Show more...Investment focus
- Industry: Robotics, Software, Manufacturing
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, Canada, China
Investor stats
- Total investments: 699
- Round size: Seed $38k–$4.5M; Pre-Seed $25k–$2M; Convertible Note $100k–$3.8M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- 5QXT — 5QXT is a mining technology company that provides the design, development, and implementation of metal extraction processes.
- XFuel — XFuel is a fuel company that provides green and clean fuels to distributors and consumers. The company was founded in 2010 and is based in Palma de Mallorca, Baleares.
- Cortysis — Cortysis develops brain stimulation device for rapid spatial and temporal modulation of cortical networks
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown, Grant
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 895
- Round size: Seed $399k–$3.2M; Grant $26k–$5.5M; Venture - Series Unknown $560k–$8.2M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $1.2M in 2021
Portfolio highlights
- Foodcloud — We connect businesses that have surplus food with Charities and Community Groups that need it.
- Amethyst Care — Amethyst Care is a startup that creates an AI-powered voice assistant for those with mobility difficulties.
- EstateMin — EstateMin provides software for law firms handling estate planning, trust administration, probate, and estate administration. Its platform supports client intake, case workflows, document organization, asset and liability tracking, and case progress visibility through a centralized dashboard. A client portal lets clients and executors submit information and documents. The platform also offers AI-supported case review and integrates with Clio.
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: France, United States, Switzerland
Investor stats
- Total investments: 1745
- Round size: Seed $752k–$6.1M; Series A $2.6M–$34M; Venture - Series Unknown $1.1M–$32M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely actively investing — fresh fund, raised $27M in 2025
Portfolio highlights
- Proteor — Proteor offers a complete range of high quality products and services to the O&P world, through more than 60 clinics.
- Advicenne — Specialty pharmaceutical company focused on the development of pediatric friendly therapeutics for the treatment of orphan renal diseases and neurology.
- BiPER Therapeutics — BiPER Therapeutics is a biotech company to develop and commercializes novel therapeutics.
Access curated startup investment opportunities and diversified venture capital exposure designed for accredited investors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 2705
- Round size: Seed $850k–$9.9M; Series A $3.5M–$32M; Series B $8M–$75M
- Lead/follow: 4% lead, 96% follow
- Last fund: Likely actively investing — fresh fund, raised $90k in 2026
Portfolio highlights
- NextDroid — NextDroid - We're Doing Something Different
- Hello Patient — Healthcare AI that gets your team off the phone & in front of patients
- Alva Energy — Alva Energy is a nuclear solution based firm that aids challenges related to nuclear power offering on time delivery of nuclear megawatts.
Founded in 2008, Par Equity is a venture capital firm that backs the most innovative, high growth technology companies in the North of the UK. Based in Edinburgh, Par invests across Northern England, Northern Ireland and Scotland.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Venture - Series Unknown, Seed
- Geography: United Kingdom, United States, Brazil
Investor stats
- Total investments: 358
- Round size: Seed $253k–$4.3M; Venture - Series Unknown $82k–$3.2M
- Lead/follow: 51% lead, 49% follow
- Last fund: Likely still investing — raised $122M in 2023
Portfolio highlights
- Fuuse — Fuuse is an electric vehicle charge point management system that enables your chargers to deliver more for you and your drivers.
- PathXL — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
- Skylark Lasers — UniKLasers specialises in single frequency, continuous wave DPSS lasers at mid- to high power. Suitable for Raman, Holography, Interferometry, Microscopy, Metrology, Quantum Technologies, and more
Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 804
- Round size: Seed $125k–$1.9M; Pre-Seed $170k–$846k; Venture - Series Unknown $201k–$2.5M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $1.9M in 2019
Portfolio highlights
- Obsero — Obsero is an AI search intelligence platform and consultancy designed for marketing and communications teams. The platform tracks, measures, and optimizes how brands surface, get cited, and are recommended across Large Language Models (LLMs) and AI search assistants.
- Surghive — Surghive provides a platform-agnostic virtual reality (VR) and AI-enabled training intelligence platform designed to solve the robotic surgical training bottleneck in healthcare.
- Overtone — Decibels Audio Ltd. is a London-based technology company that designs and manufactures Overtone, a specialized audio device engineered for personalized sound enhancement. Crafted from bio-acetate and titanium, the device utilizes a finely tuned sound engine developed alongside audiological experts to improve speech clarity and support everyday hearing experiences.
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in various sectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 851
- Round size: Seed $680k–$6.5M; Series A $3M–$31M; Venture - Series Unknown $911k–$12M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $515M in 2022
Portfolio highlights
- Extoll — EXTOLL, a leader in high-speed, ultra-low power SerDes and Chiplet connectivity, offers semiconductor IP with the smallest footprints and highest PPA. Serving global ASIC, SoC, and Chiplet markets, our portfolio includes tailored NoC (Network-on-Chip) and Die-to-Die solutions. EXTOLL drives innovation, enabling successful migration into the Chiplet Age.
- Selfapy — Selfapy offers a therapy support tool that helps recognize negative patterns of thought and train new behavior. Selfapy is your guided, self-help online course against depression with a personal psychologist as a companion.
- BlueID GmbH — Smart locks for professionals. BlueID delivers flexible, secure and convenient smart locks for all doors in and around your office.
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages. Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 1233
- Round size: Series A $4M–$45M; Series B $7.6M–$90M; Series C $12M–$120M
- Lead/follow: 51% lead, 49% follow
- Last fund: Likely actively investing — fresh fund, raised $8M in 2026
Portfolio highlights
- Nice Tuan — Nice Tuan is an e-commerce platform that provides daily groceries and miscellaneous products.
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
- Shennapsi Artificial Intelligence Technology — Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterolmonitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Keiretsu Forum is a global angel investor network with more than 2,500 accredited investor members throughout 47 chapters on 3 continents.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: United States, India, Turkey
Investor stats
- Total investments: 608
- Round size: Seed $125k–$3M; Series A $500k–$8.1M; Venture - Series Unknown $65k–$6.8M
- Lead/follow: 6% lead, 94% follow
- Last fund: May invest from a new fund soon — raised $10M in 2015
Portfolio highlights
- Bliss — Skip long waitlists and expensive therapy. Book licensed online therapists in multiple languages with culturally informed care.
- BatteryPool — BatteryPool offers battery charging solutions for EV fleets and commercial vehicles.
- Apriority Financial — In a system built for lenders, Apriority works for borrowers: no hidden lender fees, continuous rate monitoring, and we never sell your data.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004, Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Australia, United States, China
Investor stats
- Total investments: 659
- Round size: Seed $40k–$4M; Pre-Seed $29k–$535k; Venture - Series Unknown $650k–$17M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $36M in 2023
Portfolio highlights
- Vaulta — Vaulta is a battery casing technology company based in Brisbane, Australia. Using advanced composite materials and smart, streamlined design, Vaulta has developed a lighter and smaller battery case with fewer parts, creating scalable efficiencies and opportunities for manufacturers. Vaulta founder and director Dominic Spooner has over 12 yearsexperience as a design engineer, and has worked in a range of industries, including renewables and batteries, defence and aerospace, consumer products, commercial products and startups. While working in battery design, Dominic saw firsthand that opportunities for growth were being overlooked in favour of continuing with the status quo – and that’s when the idea for Vaulta was born.Vaulta’s world-first no-weld design means modules can be easily assembled and disassembled, cells reused and recycled, and new cells added as battery technology continues to evolve.From stationary storage and electric vehicles to defence, aerospace and beyond, Vaulta’s battery case technology works wherever batteries do.
- Coherence Neuro — Opto Biosystems specializes in the development of innovative healthcare technologies that bridge the gap between cancer neuroscience and bioelectronics. The company focuses on creating smaller, softer, and wireless biological interfaces designed to offer a new treatment modality. By leveraging advancements in neural engineering and bioelectronics,Opto Biosystems is dedicated to building new tools that interface with the body, aiming to improve patient outcomes in the healthcare sector. Their work includes exploring the stability of thin-film electrodes for neuromodulation, highlighting their commitment to advancing medical technology.
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
Investing Funds Designed for Women Backing Innovative Companies We Want in the World - For Returns and Impact
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Germany
Investor stats
- Total investments: 316
- Round size: Seed $1.2M–$4.3M; Series A $347k–$15M; Series B $5M–$51M
- Lead/follow: 7% lead, 93% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Kind Designs — Kind Designs is a trusted 3D Printed seawall contractor in Miami offering custom seawall construction, shoreline protection, erosion control solutions.
- AEENA Dx — A brilliant shift in disease detection is coming soon. Learn more A brilliant shift in disease detection is coming soon. Learn more
- Adjuvia Therapeutics — Adjuvia Therapeutics is a clinical-stage biopharmaceutical company pioneering blood-brain barrier (BBB)-penetrant nanoparticle therapies that address mitochondrial dysfunction, the fundamental biological mechanism driving rare and chronic degenerative diseases.
Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital to date. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 1354
- Round size: Seed $1M–$8.1M; Series A $5M–$35M; Venture - Series Unknown $72k–$13M
- Lead/follow: 1% lead, 99% follow
- Last fund: Likely actively investing — fresh fund, raised $140k in 2026
Portfolio highlights
- Allara — Allara is your all-in-one virtual care team for hormonal, metabolic & gynecological conditions such as PCOS and Endometriosis.
- North.cloud — Automate your enterprise-grade cloud finance with zero effort. Our AI reduces your cloud bill by 50% without any risk, contracts, or technical work.
- Uvi — Uvi provides infrastructure that serves as a context and reasoning layer for enterprise AI agents. The platform resolves internal corporate vocabulary, tracks dependencies, and reconstructs the decision-making intent scattered across disparate systems like Jira, GitHub, and Slack. By unifying data fragments into an integrated knowledge network, it enables AI tools to process query objectives accurately while enforcing existing user access permissions at the retrieval stage.
Khosla Ventures is a venture capital firm that invests in early- to late-stage companies across sectors like AI, healthcare, sustainability, and consumer technology. It manages multiple funds, focusing on startups with innovative technologies or business models. The firm primarily targets sectors like AI, climate tech, digital health, and medtech, offering strategic support to help build long-lasting companies.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 1552
- Round size: Seed $1.6M–$23M; Series A $5.3M–$47M; Series B $11M–$100M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely actively investing — fresh fund, raised $31M in 2026
Portfolio highlights
- Seeo — Daftar akun togel resmi bisa melalui via dana, ovo, gopay, linkaja kami juga menyediakan berbagai link togel terpercaya seperti bo togel hadiah 2d 200rb, bandar togel hadiah 4d 10 juta terpercaya, situs togel resmi dan terpercaya, agen togel terpercaya, daftar bandar togel terbesar dan terpercaya, bandar togel terbesar, situs togel prize 123, bo togel bolak balik dibayar dan banyak lainnya yang kami sediakan untuk pencinta link togel resmi di Indonesia.
- Anrok — Anrok automates sales tax compliance across your financial stack, so you can grow your SaaS business in any market.
- LanzaTech — LanzaTech offers a technology platform that transforms industrial waste gases such as carbon monoxide and carbon dioxide into valuable chemical intermediates and fuels through microbial gas fermentation. The company’s process captures emissions from heavy-industry sources and uses specialized microbes to convert those gases into ethanol, which is then refined into materials such as monoethylene glycol for packaging, solvents, proteins, and sustainable aviation fuels. LanzaTech integrates its bioconversion system with industrial emitters, enabling the reuse of carbon streams that would otherwise be released into the atmosphere, and supplies downstream manufacturers in sectors including packaging, textiles, and aviation with fossil-alternative feedstocks.
Systematic Pre-Seed Startup Capital
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Pre-Seed, Convertible Note, Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 2192
- Round size: Seed $50k–$1.5M; Pre-Seed $50k–$450k; Convertible Note $50k–$400k
- Lead/follow: 3% lead, 97% follow
- Last fund: Likely actively investing — fresh fund, raised $55M in 2025
Portfolio highlights
- Athel AI — Athel AI provides an AI-powered clinical intake platform for physicians and healthcare teams. Its tools conduct patient interviews through voice, chat, and video, capture clinical histories, and generate structured summaries for physicians. The platform also supports AI-assisted reception, dictation, multilingual interviews, and automated clinical workflows. Athel AI provides clinical decision support while keeping diagnosis and treatment decisions under the physician's authority.
- Vidrovr — Vidrovr develops multimodal computer vision and machine learning systems to index, tag, and understand video. It processes videos with specific domain constraints, such as in sports, government, and media verticals. Its technology enables its users to search an indexed video corpus and retrieve content inside videos and link it to other media likephotos and text.The company Integrates social media to enable direct interactions between multimedia content. Vidrovr was founded in 2016 and is headquartered in New York.
- TasksMind — tasksmind turns urgent but ambiguous bug reports into fixed code and customer follow-up, so bugs don't become churn.
Zürcher Kantonalbank is an independent, incorporated public-law institution is its public service mandate. Enshrined in law, it governs the bank's economic, social, and environmental commitment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Switzerland, Germany, Japan
Investor stats
- Total investments: 208
- Round size: Seed $1M–$6M; Series A $2.1M–$13M; Series B $1.7M–$20M
- Lead/follow: 13% lead, 87% follow
- Last fund: Likely still investing — raised $150M in 2024
Portfolio highlights
- Riverkin — Riverkin builds rugged, low-cost water sensor systems for rivers that measure turbidity and temperature in real time. Our platform turns field data into clear insights and decision making tools.
- QualySense — QualySense is a Swiss start-up company focused on innovative high-throughput grain, beans and seeds sorting technology. QualySense develops a high-speed multi-tons per hour sorting device, which will change how grains, beans and seeds are processed and valued worldwide by assessing the biochemical quality of grains one by one. The QualySensesorters will enable customers to separate grain batches into different biochemical quality classes and sell the corresponding premium products at higher average prices. Food processors will be able to considerably increase the production value, and produce higher quality products in a non-interrupted process.
- Pearltec AG — Headquartered in Schlieren / Zurich, Pearltec AG develops, produces and delivers solutions for the optimal storage, fixation and positioning of patients. Their products are based on unique, patented technology developed in collaboration with ETH Zurich and renowned university hospitals.They have set theirselves the goal to use the technologycompetence of Pearltec AG for the benefit of humans, animals and industry and to create added value for their customers by excellent quality and convincing application advantages.Pearltec AG is certified according to ISO standard 13485. This certification certifies that their quality management system for the development and manufacture of medical devices meets the highest international standards.
Foundational partners to ambitious founders at every stage of company-building.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: United States, China, India
Investor stats
- Total investments: 2171
- Round size: Series A $5.7M–$53M; Series B $10M–$85M; Series C $15M–$100M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $468M in 2024
Portfolio highlights
- Uhana — Modernize your RAN to be open and programmable, built with a rich ecosystem of partners. Learn about VMware RAN Intelligent Controller (RIC).
- erytech — ERYtech Pharma, set up in Lyon (France) in 2004, specializes in the encapsulation of therapeutic molecules and enzymes in red blood cells. It has achieved a major breakthrough in the fields of cancer and enzyme therapy by significantly increasing the therapeutic index of the encapsulated molecule or enzyme.
- Sportsrocket — Sportsrocket is a New York-based company working to give sports fans access to live games and events, highlights, and shows. The company works with leading leagues, publishers, and rights-holders, including Major League Soccer, the PGA Tour, Scout Media, and AS Roma, to create and power customized OTT platforms. Incubated by Bedrocket Media Ventures, Sportsrocket's innovative approach is based on a proprietary sports media operating system, that offers an integrated solution for the production, distribution, management, and monetization of sports media across all platforms.
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 347
- Round size: Seed $100k–$5M; Series A $1.4M–$23M; Venture - Series Unknown $350k–$12M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- deets — deets Inc., is a Westport, Connecticut-based mobile technology company dedicated to improving people’s lives and productivity through meaningful, on-the-go sharing and collaboration solutions. Founded in 2011 by the former leadership of successful online companies including Priceline and Hotwire, deets launched its first product in 2012. ItsMobile and Web communication software dynamically synchronizes contacts and lets users manage group conversations and collaboration all from a single mobile dashboard. For more information on deets, please visit www.sharedeets.com.
- Umbie Health — Umbie Health Corporation, an East Hartford, Conn.-based that develops a Web-based and mobile practice management application for dentists.
- Axerion Therapeutics — Axerion Therapeutics, Inc. is a private Connecticut-based biotechnology company focused on developing innovative therapeutics for neurological diseases and injuries with significant unmet medical need, including Alzheimer’s disease and spinal cord injury.Axerion was established in New Haven to develop and commercialize intellectual propertylicensed from Dr. Stephen Strittmatter’s laboratory at Yale University. Axerion’s proprietary technology platforms include blockers of ß-amyloid (Aß) oligomers binding to Prion Proteins (PrP) on the cell surface of neurons as a novel therapeutic target for Alzheimer’s disease and Nogo Receptor decoy protein for recovery of neurological function in spinal cord injury and other neurological diseases.
TEDCO is an independent organization that strives to be Maryland’s lead source for entrepreneurial business assistance and seed funding for the development of startup companies in Maryland’s innovation economy.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Grant, Pre-Seed
- Geography: United States, Canada, Colombia
Investor stats
- Total investments: 344
- Round size: Seed $100k–$2.5M; Grant $54k–$1M; Pre-Seed $25k–$900k
- Lead/follow: 70% lead, 30% follow
Portfolio highlights
- ReBokeh — ReBokeh is a mobile application that offers visually impaired video filters to enhance the users' vision.
- AGED Diagnostics — AGE Diagnostics develops diagnostic tools for nonalcoholic steatohepatitis (NASH, liver disease) and fibrosis (liver scarring). AGED tools can simultaneously stage fibrosis and distinguish benign from severe liver disease (liver scarring). This method measures the concentration of target biomarkers (genetic signatures) in circulation using atargeted genomic sequencing assessment. When biomarkers are detected over a specific quantity, liver disease (NASH) and/or fibrosis are diagnosed.
- Allegany College of Maryland — The main campus of the Allegany College of Maryland rests in Cumberland, off of Willow Brook Road. As the biggest of the school’s three campuses, Cumberland has all of the amenities you may never have expected from a small college. Each building is equipped with the latest modern facilities, making for an up-to-date learning experience. There arealso dining areas, a student lounge, and a state of the art physical education building with a gym and swimming pool.Within the list of extensive fields of study are the social, biological and political sciences, criminal justice and criminology, many fields in the humanities, accounting and business programs, automotive and other technical studies, culinary arts, hotel and restaurant management, forest technology, health fields including dental hygiene, physical education, nursing, and pharmacy technician studies, and more. Advice is not something you’ll be lacking at Allegany. The tutoring services can help you through any academic rough patches. Transfer advising can prepare you to go to a four-year college. Career advising counselors can help you pick a major, assess your interests and aptitudes, and help find you a career.Along with federal financial aid and veteran’s benefits, Allegany also offers a catalog full of scholarships from major related aid to local endowments to eligible students.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The Foundation for Technology Innovation gives financial assistance to creative and technological projects at various phases of development. FIT funds projects in energy and the environment, information and digital technology, life sciences and health, precision industries, and nutrition and agriculture.
Show more...Investment focus
- Industry: Health Care, Information Technology, Artificial Intelligence
- Stage:Debt Financing, Grant, Seed
- Geography: Switzerland, France, United States
Investor stats
- Total investments: 292
- Round size: Seed $100k–$2.5M; Grant $20k–$125k; Debt Financing $100k–$532k
- Lead/follow: 94% lead, 6% follow
Portfolio highlights
- PolaSight — PolaSight delivers a direct, label free visualization of fresh tissue through its automated PolaOne benchtop polarimetric imaging platform. The technology utilizes multi spectral polarimetry to reveal quantitative physical contrast and microstructure details beyond what conventional stained slides show. This non destructive, AI ready optical mapping process provides standardized tissue data right at the bench without requiring freezing or chemical reagents.
- Swiss Soil — Live biological sensing, adaptive decision-making, and precision inputs that cut waste, respond to real conditions, and build healthier soil.
- Biodelphis Therapeutics — Swiss biotech developing next-generation protease inhibitors using Antibody-Peptide Inhibitor Conjugates (APIC).
Verticals:Enterprise, SaaS, Security, Networks, AI, VR/AR, Marketplace, Blockchain, Internet of Things, New materials, Electronics, Robotics, Cleantech, Agrotech, Seatech, Therapeutics, Digital Health, Diagnostics, Innovative Accommodation, Tourist Entertainment Companies, Tour Operators, Wine, Nautical and Equestrian Tourism, Theme Parks Mobile, Robotics Founded in 2012, Portugal Ventures is a venture capital firm based in Porto, Portugal. The firm is a part of the Banco Português de Fomento group. The firm seeks to invest in pre-seed, seed and series A stages
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Portugal, United States, United Kingdom
Investor stats
- Total investments: 409
- Round size: Seed $121k–$1.9M; Pre-Seed $107k–$796k; Venture - Series Unknown $121k–$3.6M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Fetalix — Fetal-inspired solutions for tissue regeneration
- Unlockit — Unlockit will offer to public and governmental bodies the guarantee that everything within a real estate transaction is recorded, meaning better industry regulation, more taxes and public fees collected, and less overall fraud and money laundering activities.
- Outgoing — A ticketing tool that allows organizers to sell tickets directly on WhatsApp and Instagram. Users can purchase tickets through a personalized checkout process entirely within the chat, without registration or redirects. It also offers customer support that answers questions in real time.
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009, anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth. Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Philippines
Investor stats
- Total investments: 356
- Round size: Seed $991k–$4.9M; Series A $1.6M–$14M; Series B $1.7M–$44M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Adsilico — Explore how virtual populations and in silico trials help medical device teams understand variation and build stronger evidence.
- Illumion — Illumion develops high-throughput optical tools to accelerate battery material development
- MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
IndieBio, re-named SOSV SF and SOSV NY in 2026, are two of SOSV’s three deeply resourced facilities for deep tech founders. The third is SOSV's HAX, in Newark, NJ. SOSV is the most active deep tech venture capital firm globally.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 676
- Round size: Seed $250k–$5M; Pre-Seed $50k–$525k; Convertible Note $150k–$950k
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- FluoSphera — Fluosphera better predicts the effects of molecules through animal-free microphysiological systems, helping you to discover more efficient drugs with less adverse side effects.
- Giraffe Bio — Giraffe Bio uses AI and biomolecules to optimize metal extraction, increase yield, and reduce environmental impact. Revolutionizing sustainable mining technology.
- Transition Metal Solutions — Transition harnesses wild microbial communities to recover copper and other critical metals from low-grade mining resources.
Keiretsu Capital LLC is an affiliate of the World's Leading Angel Network, Keiretsu Forum, and manages funds which enable limited partners to co-invest in the proprietary deal flow of the angel investors.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Convertible Note, Seed
- Geography: United States, Canada, India
Investor stats
- Total investments: 288
- Round size: Seed $400k–$2.5M; Series A $811k–$12M; Convertible Note $50k–$3M
- Lead/follow: 1% lead, 99% follow
- Last fund: Likely still investing — raised $3.7M in 2022
Portfolio highlights
- MiClient — Miclient are deal closure platform which was founded by experienced sales leaders who recognized the need for a new generation of complicated quote configuration, contract signing, renewal & payment collection at one place for SMEs, Lead Management System, B2B SaaS, CRM software, CPQ (Configure- Price- Quote)
- Healionics — Healionics aims to provide safer, more reliable means of bloodstream access for dialysis in patients with kidney failure.
- NuvOx Therapeutics — NuvOx Pharma is a clinical stage biotech company developing an innovative platform of oxygen therapeutics to treat life-threatening diseases where hypoxia plays a role.
Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science. We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions, industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress. With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik. Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network. Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Venture - Series Unknown, Seed
- Geography: Sweden, Norway, United States
Investor stats
- Total investments: 600
- Round size: Seed $226k–$2.2M; Venture - Series Unknown $338k–$3.5M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $64M in 2024
Portfolio highlights
- Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
- Indevex AB — Indevex is a science-based and privately owned biotech company from Sweden. A natural and reliable partner, providing evidence based natural nutrition concepts based on the patented NGC™ Formula.
- Xaga Surgical — Xaga Surgical aims to minimize the risk of infections by inventing safer medical needles.
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures. The Foundation Leducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support. With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Series B
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 86
- Round size: Seed $1M–$18M; Series A $1M–$20M; Series B $2.5M–$45M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Adient Medical — Medical Devices that Automatically Vanish - Adient Medical is leading the development of an absorbable vascular filter for the prevention of pulmonary embolism.
- HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
- Viridian Therapeutics (Formerly MiRagen Therapeutics) — Viridian Therapeutics is leveraging core expertise in antibody discovery to develop optimized treatments for rare autoimmune conditions
New York Angels is one of the oldest, most prominent angel investment groups in the country. New York Angels has offered early-stage entrepreneurs funding, mentoring, connections and more for over 20 years. Angel investors join New York Angels for their extensive, experienced network, increased de
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 417
- Round size: Seed $365k–$5M; Pre-Seed $40k–$1.7M; Series A $1.1M–$10M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $2.4M in 2022
Portfolio highlights
- Solidec — Solidec is the pathway to emission-free compounds, beginning with hydrogen peroxide.
- Epicured — Epicured delivers gourmet low-FODMAP, gluten-free meals by chefs for digestive health. Tasty cuisine right to your door.
- Dirty Shirley — The #1 Dirty Shirley drink is now a Dirty Shirley cocktail in a can. Our delicious Dirty Shirley cocktails deliver the perfect drink for all occasions.
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more...Investment focus
- Industry: Health Care, Medical, Wellness
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 407
- Round size: Seed $100k–$3.5M; Pre-Seed $20k–$854k; Venture - Series Unknown $150k–$15M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — raised $31M in 2018
Portfolio highlights
- AvoMD — AvoMD is reimagining clinical decision support with interactive point-of-care software, available standalone and via EHR integrations, and seamless content building tools.
- Hidoc Consult — Hidoc Consult: Boost your well-being with free consultations, 24/7 access to quality healthcare, complete privacy, user-friendly, and a trusted network of HCPs
- NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 360
- Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $755M in 2025
Portfolio highlights
- Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
- IMIO — Improve efficiency across the crop nutrient cycle. IMIO natural microbial products reliably increase nutrient availability and reduce tillage.
- DMC Biotechnologies — Transforming How the World Makes Chemicals
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!First Citizens Innovation Banking works with technology, life science, cleantech, venture capital, private equity, and premium wine businesses. SVB provides industry knowledge and connections, financing, treasury management, corporate investment, and international banking services to its clients worldwide through 27 U.S. offices and seven international operations. Banking innovative companies and exclusive wineries, Silicon Valley Bank’s diverse financial services, knowledge, global network, and world-class service increase its clients’ probability of success. Forbes Magazine ranks SVB among America’s Best Banks, and Fortune Magazine named SVB one of the Best Companies to Work For in 2012.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Debt Financing, Series B, Series A
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 846
- Round size: Series A $4M–$26M; Series B $8M–$50M; Debt Financing $2M–$100M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Zogenix — Therapeutic Solutions for CNS Disorders and Rare Diseases
- Capitolis — Capitolis is the technology company helping to create safer and more vibrant financial markets by unlocking capital constraints and enabling greater access to more diversified capital and investment opportunities. Rooted in advanced technology and deep financial expertise, Capitolis powers groundbreaking financial solutions that drive growth forglobal and regional banks – and institutional investors alike.
- Torch Systems — Ultra early fire detection and analytics platform. Built for communities, enterprises, and the environment
CincyTech helps to identify and transform innovation into venture-worthy, transformational human health and technology companies, primarily in southwest Ohio. Our team provides advice and capital to entrepreneurs, helps research institutions commercialize technology through startups, and catalyzes investment from individuals and institutions into regional companies. One of the most active seed funds in the Midwest, CincyTech is supported by Ohio Third Frontier, more than two dozen foundations, corporations, municipalities and individuals as well as founding partners, Cincinnati Children’s Hospital Medical Center, the University of Cincinnati, and the Cincinnati USA Regional Chamber.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States
Investor stats
- Total investments: 132
- Round size: Seed $250k–$3.9M; Series A $300k–$20M; Series B $2.5M–$11M
- Lead/follow: 53% lead, 47% follow
- Last fund: Likely still investing — raised $2.8M in 2022
Portfolio highlights
- Invirsa — Invirsa is developing a unique, broad platform based on a naturally occurring small molecule (INV-102) that has demonstrated enhanced immune response to infection. INV-102 not only reduces viral infection, and potentially bacterial replication, it also reduces inflammation, while enhancing the bodies wound healing response. Invirsa'stechnology is first being developed in the ophthalmology and pulmonary space.Invirsa’s technology has the potential to be a first line therapy for common infectious diseases, whether it's the 100 million viral pulmonary infections or the 5 million infectious conjunctivitis cases that occur every year in the US alone.
- TeamCentral — TeamCentral is a company focused on optimizing productivity through improvements in how data is managed and governed across business systems.
- Ravee Optics — Ravee Optics is a startup company developing ultracompact optical intersatellite links and hardware technology for high data rate communications and data transfer for small satellites and cubesats
Upstate New York's most active nonprofit seed fund. Free mentoring, seed capital, and hands-on support for high-growth startups. 2,020+ companies mentored, 110+ funded, 10,500+ jobs created.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Convertible Note, Seed, Pre-Seed
- Geography: United States, Canada, Denmark
Investor stats
- Total investments: 248
- Round size: Seed $50k–$2.2M; Pre-Seed $81k–$1.1M; Convertible Note $18k–$1M
- Lead/follow: 61% lead, 39% follow
- Last fund: Likely still investing — raised $16M in 2023
Portfolio highlights
- Ognomy Sleep — Are you looking for a sleep apnea app? Ognomy brings the high-quality care you can expect from an online sleep doctor. Our mission is to improve global health by democratizing access to care for those who suffer from sleep apnea - over 1 billion people worldwide.
- CryoBio — CryoBio offers a food-safe spray solution to protect crops from extreme frost, reducing losses and replacing manual labor with effective, biodegradable frost protection technology.
- Bridge Green Upcycle — Bridge Green Upcycle is a clean energy company that specializes in lithium-ion battery upcycling technology solutions.
For over two decades, Sand Hill Angels has worked openly and collaboratively with venture capital funds, other angel organizations, and the Bay Area ecosystem that fosters the growth of technology startups.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Convertible Note, Series A
- Geography: United States, Canada, India
Investor stats
- Total investments: 642
- Round size: Seed $1M–$6M; Series A $1.6M–$20M; Convertible Note $300k–$25M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Ampaire — Ampaire is making flying more accessible to more people from more airports by developing electric aircraft that are safe, clean, quiet, and less costly.
- PlusPlus — PlusPlus provides a learning and development SaaS platform for technical professionals. It automates the management of onboarding, workshops, and tech-talks at scale. With PlusPlus, companies attract and develop employees.
- Magnetic Insight — Magnetic Insight (MI) introduced magnetic particle imaging into the preclinical diagnostic research market enabling quantitative cell tracking, imaging of vascular function, detecting metastatic tumors, visualizing inflammation, CAR-T cell therapies and initial research into regenerative medicine.
TCA Venture Group is the largest angel investor group in the United States, possessing more than 300 members in five networks in Los Angeles, Orange County, San Diego, Central Coast, and the Inland Empire. Its members provide funding and guidance to more early-stage, high-growth companies in Southern California than any other investment group. Members invest in companies in a wide range of industries, including the life sciences, biotech, IT, services, retail, Internet, financial, software, media, consumer products, and tech startups. TCA as a whole gives companies more than just capital; they also provide counsel, mentoring, and access to an extensive network of potential investors, customers, strategic partners, and management talent. Tech Coast Angels has been ranked by CB Insights to be among the Top 20 Angel Groups in the US; TCA was also ranked as #1 for Network Centrality, meaning we have more connections than anyone! If you are in the game-changing business, we are here to help.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Venture - Series Unknown, Convertible Note
- Geography: United States, Canada, South Africa
Investor stats
- Total investments: 431
- Round size: Seed $523k–$3.7M; Convertible Note $100k–$4.5M; Venture - Series Unknown $500k–$6.2M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- EdgeX — Edokonta builds software that allows hospitals to track mobile equipment, such as IV pumps and ultrasounds. The company was founded in 2018 and based in San Diego, California.
- Nested Knowledge — Nested Knowledge is designing an interface that allows you to examine the data from a comprehensive literature review on research questions of interest. The interactive, nested features facilitate therapeutic comparisons, assist with research organization, and allow physicians to compare nuances across patient characteristics and outcomes.
- Major Medical Devices — Major Medical Devices develops next-generation vascular devices for endovascular repair and related surgical procedures.
U.S. Venture Partners (USVP) is a venture capital partnership, helping entrepreneurs transform their ideas and efforts into world-changing companies. The firm focuses on early-stage ventures in information technology and health care, where innovation is unbridled and has led to the creation of economic wealth and millions of jobs over the past thirty-plus years of the firm's existence. Areas of particular interest to our investment professionals include enterprise software, IT security, consumer internet, mobile, and e-commerce, healthcare, and IT-enabled healthcare services. The USVP team consists of former entrepreneurs, technologists, corporate executives, financial professionals, and industry domain experts.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series B, Series C, Series A
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 493
- Round size: Series A $4.7M–$40M; Series B $6.8M–$50M; Series C $7.8M–$68M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $400M in 2022
Portfolio highlights
- Dotomi — We create enriched customer experiences that drive performance at the individual and business level, enabling marketing built on proof, not promises.
- HighLife — HighLife is driven by a mission to deliver innovative treatment options to patients suffering from heart valve diseases.
- ReEmerge — ReEmerge is a medical technology company that develops Cognitive Network Restoration Therapy, a neurostimulation approach designed to address chronic cognitive impairment following brain injury. Its technology uses targeted electrical stimulation of neural networks to activate underperforming but viable brain circuits, with the goal of improving cognitive function and supporting recovery in patients with persistent impairments.
Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Indonesia
Investor stats
- Total investments: 373
- Round size: Seed $45k–$1.3M; Series A $295k–$10M; Venture - Series Unknown $363k–$3.6M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $20M in 2024
Portfolio highlights
- OneClickComply — OneClickComply automates ISO 27001, SOC 2, Cyber Essentials and 240+ standards: evidence from 13,000+ tools, one-click fixes and an in-house audit team.
- Land Digital — Land Digital is a tech, web design, web creation, content marketing, digital marketing, SEO, and mobile application agency.
- Magnitude Biosciences — Magnitude Biosciences is a biotechnology firm combine experience in ageing research, the nematode C. elegans and automation.
Private angel investors and corporate venture ecosystem investing in healthtech, digital health and other healthcare technologies startups
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A, Convertible Note
- Geography: United States, Canada
Investor stats
- Total investments: 101
- Round size: Seed $1M–$4.3M; Series A $1.7M–$16M; Convertible Note $1.3M–$2.5M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- S2 Genomics — S2 Genomics is developing spatial sequencing technology solutions for processing solid tissues for single-cell applications. It enables automated processing of raw tissues into single cells or nuclei for genomics and cell biology studies. The company's vision is to provide products that process raw tissues into samples ready for genomicanalyses.S2 Genomics was founded in 2016 and is headquartered in Livermore, CA.
- Journey Live — Journey is shifting the way modern companies prioritize mental health. Our proactive, inclusive tools engage every employee, every day.
- GT Metabolic Solutions — GT Metabolic Solutions has developed minimally-invasive incisionless bypass technology for bariatric, metabolic and digestive surgery.
Providing Flexible and Creative Financial Solutions to Middle Market Companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Debt Financing, Post-IPO Debt, Venture - Series Unknown
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 144
- Round size: Post-IPO Debt $15M–$150M; Debt Financing $5M–$75M; Venture - Series Unknown $8.3M–$31M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Inhibrx — Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The Inhibrx pipeline is focused on oncology,orphan diseases, and infectious diseases. Inhibrx has collaborations with Celgene and Bluebird Bio and has received awards from several granting agencies, including NIH, NIAID, and CARB-X.
- Vortexa — State of the art energy analytics that paints a global picture of cargo flows. Identify energy market opportunities before the competition with Vortexa.
- Serena & Lily — Design-driven luxury furniture, bedding, home accessories & interior design. Explore Serena & Lily's proprietary products and personalized service to create a home on your own.
Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Ireland, United States
Investor stats
- Total investments: 45
- Round size: Seed $702k–$3.9M; Series A $2.2M–$11M; Venture - Series Unknown $753k–$17M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- Peroptyx — Peroptyx is a platform that provides managed solutions for machine learning. At Peroptyx, they have assembled and pre-screened a qualified network of data evaluators across the globe. They strategically match ideal evaluators with each product to ensure authentic experiences through consistency and appropriate real-world contexts.
- Galway Biomedical — Galway Biomedical partners with global medical device companies to bring complex braided devices from early concept through to full-scale production.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Good Growth Capital is an early-stage venture capital firm known for its expertise in finding, assessing and cultivating complex science and technology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Convertible Note
- Geography: United States, France, Israel
Investor stats
- Total investments: 130
- Round size: Seed $505k–$8.2M; Series A $4.2M–$24M; Convertible Note $25k–$300k
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $43M in 2023
Portfolio highlights
- Ateios — Ateios is enabling a new generation of thin and flexible electronics with our ultra-thin, conformable, and customizable batteries. The company's current focus is zinc-oxide batteries, that achieve 2-5x higher energy density compared to coin cells. Ateios’ novel manufacturing process allows customizable batteries that can be shaped around theneeds of the product.The company was founded in 2018.
- Obsidio — Obsidio™ Conformable Embolic with aqueous gel technology is a 510(k) cleared device, the first of its kind to have a specific on-label indication for peripheral use in the U.S.
- Avisi Technologies — Avisi Technologies is developing a nanotechnology-enabled defense against blindness from glaucoma.
Eniac Ventures is a venture capital firm that focuses its seed-stage investments in technology, software, robotics, and SaaS startups. The firm partners with bold founders to help them achieve product-market fit and grow their companies from inception to success. With each fund, the approach of Eniac Ventures has evolved and expanded to address the growing needs of portfolio companies. Founders are encouraged to focus on their product, which led to the creation of the Eniac Platform. Term sheets represent just the initial step; companies partnering with Eniac benefit from a range of complimentary support services. These include access to a talent recruiter dedicated to finding top employees, particularly in engineering, as well as a public relations and marketing specialist to help products reach key audiences from launch through growth. Additionally, operational resources are provided to help organize staff and implement best practices. Business development and networking opportunities are available with thousands of leading companies, investors, and brands. Furthermore, connections to other founders within Eniac’s portfolio facilitate the exploration of synergies and opportunities. Fundraising support encompasses guidance on pitch decks, strategies for follow-on investors, and syndicate building.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Mobile
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Spain
Investor stats
- Total investments: 775
- Round size: Seed $1.1M–$5.5M; Series A $6.5M–$20M; Series B $5M–$40M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — raised $12M in 2024
Portfolio highlights
- GenHealth.ai — GenHealth.ai provides healthcare solutions using generative AI trained on encoded medical events. Its product is a generative healthcare AI publicly available. It includes a foundation transformer model (new neural networks with excellent memory), an API, and user applications that can generate and predict future sequences of health events usinghistorical events. Together they can be used to build a large variety of customized applications.
- Dynamic Creatures — Dynamic Creatures creates responsive character robots for the entertainment and service sectors.
- Nebex — NEBEX is a successful middle market investment intermediary. NEBEX, has completed over 100 transactions throughout the United States. New England Business Exchange concentrates on representing sellers whose business appeals to large corporate buyers or private equity groups.
Social Starts is a $60M+ venture capital partnership with a uniquely data-driven approach to investing in moment-of-inception and Series A financing rounds.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United States, Canada, Germany
Investor stats
- Total investments: 472
- Round size: Seed $50k–$3.6M; Series A $3.3M–$14M; Venture - Series Unknown $626k–$5M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely still investing — raised $8.9M in 2022
Portfolio highlights
- Hey Jane — Get safe, effective and affordable abortion pills delivered fast to your home. Hey Jane is the first digital abortion clinic, connecting you to licensed providers in your state through telemedicine.
- Mae Health — Mae is a maternal health platform that connects expectant mothers with critical resources to drive positive pregnancy outcomes.
- Ruby Bio — Ruby Bio is a biosynthesis platform that can manufacture complex molecules that are biodegradable and non-toxic. Ruby Bio uses naturally occurring yeast as a factory to convert low-cost sugar into high-value products.
Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 308
- Round size: Seed $1.3M–$12M; Series A $2.1M–$18M; Series B $3.9M–$45M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — raised $61M in 2022
Portfolio highlights
- Piomic — Non-invasive treatment with minimal staff supervision to produce a durable structural, functional and cosmetic closure of hard-to-heal wounds.
- Turn2x — TURN2X decarbonizes the industry by producing Renewable Natural Gas with a unique methanation process.
- Undecimal Bio — Undecimal Bio operates as a platform biotechnology company that develops targeted delivery mechanisms for small interfering RNA (siRNA) therapeutics. The company utilizes a proprietary platform that combines combinatorial chemistry libraries with transformer-based artificial intelligence to discover molecular conjugates capable of guiding genetic medicines to specified cells outside of the liver. This approach aims to circumvent traditional delivery constraints to expand the reach of RNA therapeutics into a broader range of therapeutic areas and human organs.
MB Venture Partners in Memphis, TN provides venture capital for life sciences: medical device, biotechnology companies, products for musculoskeletal diseases
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Series B, Series C
- Geography: United States, Israel
Investor stats
- Total investments: 92
- Round size: Seed $50k–$800k; Series B $1.3M–$18M; Series C $5M–$28M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $22M in 2011
Portfolio highlights
- Cast21 — The future of orthopedic technology has arrived. Cast21 braces are designed for your active lifestyle.
- SweetBio — SweetBio is a Memphis, Tennessee based medical device company specializing in bioengineering honey-incorporated materials for wound care.
- Lineus Medical — Lineus Medical is a medical device company focused on reducing IV complications for patients and providers all over the world.
Early Stage Venture Investments
Show more...Investment focus
- Industry: Health Care, Medical Device, Software
- Stage:Seed, Convertible Note, Series A
- Geography: United States, Canada, Hungary
Investor stats
- Total investments: 104
- Round size: Seed $105k–$3M; Series A $3M–$10M; Convertible Note $2.5M–$2.6M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $175k in 2021
Portfolio highlights
- Flourish Care — FlourishFund is a digital platform that empowers and supports new and expecting families. The platform consists of two parts: a marketplace with evidence-based goods and vetted maternal wellness services and a funding mechanism for friends and families to contribute to a positive birth and parenting journey.
- Drusolv Therapeutics — Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention in age-related macular degeneration. Their product ocustatin is aimed at patients who are still in the intermediate stage of the disease and currently have very limited options to prevent progression to late-stage vision loss. Ocustatinwas developed at Harvard University and has been validated in a very successful proof-of-concept clinical trial that showed a 75% reduction in progression to late-stage blindness. John Edwards, the founder and CEO of Drusolv, is a serial entrepreneur with extensive experience in AMD.
- Vartega — Vartega is a technology development company specializing in the carbon-fiber-reinforced plastic recycling process. Vartega develops alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass-market applications.Vartega's patented carbon fiber recycling process scales rapidly to fill a gap in thecomposites supply chain. The company’s carbon fiber is available in semi-continuous, chopped, and milled forms. It is ideally suited for use in thermoplastics, non-wovens, and molding compounds.
Boston Harbor Angels is a group of proven business leaders interested in investing a portion of their assets in high growth, early stage companies. The group was formed in February 2004 and since then has made a number of investments in companies in medical devices, IT, consumer products, business products, specialty materials, Internet, aviation, etc. They believe they contribute more than money to the companies they fund and welcome the opportunity to work with entrepreneurs open to take advice, yet having the smarts and determination to make the company successful. Their focus is on early stage companies usually looking to raise $250K to $1.5M, where they can fund a portion of the round and syndicate the deal with other angel groups or early stage venture funds. The stage of the company should be close to commercialization, while the company should have a clear and defensible competitive advantage. They are looking for capital efficient businesses, which can reach profitability with less than $5M of equity investment and provide at least 10X return on the investment within 5 years. They do not invest as a fund - each of their members makes his or her individual investment decision but they collaborate in Due Diligence. They have a deep expertise in the life sciences field where they usually take the position of a lead investor, but are open to any opportunities that can make a strong business case. In some cases they prefer to be the follow on investor if they cannot identify a person with strong expertise within their group. The group’s strategy is directed by an executive committee which consists of 8 people elected by the group: Wayne Griffith (chairman), Bill McPhee, Henry Kay, Jay Schwartz (membership director), Steve Andress, Peter Miller, Don Freeman and Mic Williams (president and founder). The group’s day-to-day operations are managed by Boris Batchvarov (managing director). They receive 20-30 business summaries each month, out of which they select 8 companies to make a personal presentation to their screening committee. The screening committee consists of volunteers from the group. The presentations are 10 min long followed by 10 min Q&A. 4 of the companies are invited to present to the whole group, with the idea to get the people interested and decide to perform a Due Diligence with the companies before making an investment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Angel, Seed, Series A
- Geography: United States, Canada, India
Investor stats
- Total investments: 109
- Round size: Seed $100k–$2.9M; Angel $500k–$1.6M; Series A $662k–$6M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Gelmedix — Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment. The company's platform offers a single non-invasive gel patch that can be used as a drug-eluting sealant with tissue adhesion, tunable drug elution, and biocompatibility properties, thereby enabling healthcare providers to reducethe usage of drops which cause inconvenience to patients.
- Zylö Therapeutics — Patented technology that enables, for topicals, sustained release, increased druggability, a Patchless Patch concept, and enhanced targeting of pores and follicles
- Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Everywhere Ventures is a global pre-seed venture capital fund for founders, by founders. Click to read Everywhere VC, by Everywhere Ventures, a Substack publication with tens of thousands of subscribers.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Australia
Investor stats
- Total investments: 1308
- Round size: Seed $1M–$6.5M; Pre-Seed $250k–$2.5M; Series A $6M–$20M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely actively investing — fresh fund, raised $4.4M in 2026
Portfolio highlights
- Donna — Meet Donna, the AI assistant built for field sales teams. Save time, cut admin, and close more deals with less effort.
- Netsec — Professional cybersecurity and managed IT services to protect your business 24/7.
- Electric Plant Company — We are a plant intelligence company transforming plant care today and accelerating the techno-biophillic future of tomorrow.
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 339
- Round size: Series A $4.7M–$68M; Series B $10M–$105M; Series C $12M–$107M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — raised $5M in 2024
Portfolio highlights
- Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
- Gate Bioscience — Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease.
- Dayra Therapeutics — Dayra Therapeutics manufactures peptide based medicines.
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Grant, Pre-Seed, Seed
- Geography: United Kingdom, Spain, Ireland
Investor stats
- Total investments: 106
- Round size: Seed $220k–$1.4M; Grant $27k–$1.6M; Pre-Seed $45k–$1.7M
- Lead/follow: 59% lead, 41% follow
Portfolio highlights
- IDOVEN — Idoven has developed the world’s first AI cardiologist -Willem- that augments both a cardiologist’s and non-cardiology expert clinician’s ability to identify, triage and diagnose patients at scale through APIs. The company counts clients such as AstraZeneca, Abbott, Novartis, GE Healthcare, FIFPRO, Google, Santander and Real Madrid Foundation.Idoven is backed by top-tier investors and business angels including Insight Partners, Northzone and Wayra (Telefónica), Iker Casillas, Pau Gasol, the Accel Starters program, EIC Accelerator, Horizon 2020, ERC and EIT Health. The company has been awarded with numerous distinctions for its AI technology in Europe and the US, including the the European Seal of Excellence 3x from the European Commission, granted by Horizon 2020, European Research Council ERC 2x (RIA) Europe’s most prestigious research grant, supporting excellent researchers in carrying out ground-breaking, high-risk, high-gain, frontier research projects, EIC Accelerator, and EIT Health. Idoven was ranked #1 Spanish HealthTech company in 2020 by NEOTEC. Idoven has been Google for Startups Resident at Google Campus Madrid and part of the Google for Startups Global Alumni Program. The company has won the prize Emprendedor XXI from CaixaBank, the Healthy Longevity Catalyst Award from the U.S. National Academy of Medicine, and has been awarded at South Summit 2021 as the Most Disruptive Startup, and Best Health and Wellbeing Startup. Selected by CB Insights as one of the top 150 global companies in Digital Health for 2022, and top 50 global companies in Digital Health for 2023. Idoven was recognized by TIME Magazine as one of the World's Top HealthTech Companies of 2025.
- Noah Labs — A breakthrough for heart failure: Noah Labs Ark is a Class IIa Medical Device Software with AI-driven detection of early cardiac decompensation through voice.
- Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
Medical Device VC funding at a glance
Stats across 19k deals from 11k investors.
Access all 11260 VC funds in Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device VC Funds investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 11260 VC funds investing in Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!